Effects of vasoactive drugs on lysosomal stability in vitro.
D000135:Acid Phosphatase / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D002458:Cell Fractionation; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival; D002746:Chlorpromazine / Q000494:pharmacology*; D005966:Glucuronidase / Q000378:metabolism; D006358:Hot Temperature; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology*; D008833:Microcirculation / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D051381:Rats; D012769:Shock / Q000517:prevention & control; D013223:Statistics as Topic
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine; D000135:Acid Phosphatase; D005966:Glucuronidase; D002746:Chlorpromazine; D008775:Methylprednisolone; D010646:Phentolamine